Last update:
Oncology news
'Bugs delivering drugs': A new approach to colorectal cancer treatment using common food-borne bacteria
Baylor University researchers have developed a novel approach to fight colorectal cancer, using modified bacteria as a courier to deliver potent cancer-killing proteins into tumor cells. Michael S. VanNieuwenhze, Ph.D., FRSC, ...
12 hours ago
0
0
Dark sweet cherries may help slow aggressive breast cancer, mouse study suggests
From cobblers to smoothies, dark sweet cherries show up in plenty of recipes, and scientists say the crimson-colored fruit may contain compounds that could help fight an aggressive type of breast cancer.
14 hours ago
0
0
What pet cats can tell us about human cancer
They live in our houses, drink our water and even sleep in our beds. Cats have become an integral part of many households and share much of our lives. They also share much of their biology with humans. Pet cats get cancer ...
8 hours ago
0
0
Blood tests for cancer? We're still a way off
A new kind of blood test promises to find cancer early—sometimes even before symptoms appear. The pitch is compelling: a single sample of blood could scan the body for dozens of different cancers at once, catching disease ...
4 hours ago
0
0
Telehealth visits may help breast cancer patients stay on treatment
Staying in touch with doctors online could help breast cancer survivors keep up their cancer treatment, according to a recent study from the University of Georgia published in the Journal of Cancer Survivorship.
15 hours ago
0
0
Study: Additional radiation for liver cancer does not increase toxicity
New research from a University of Cincinnati Cancer Center study found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy ...
12 hours ago
0
0
Study maps three biological routes for gastric cancer beyond H. pylori
A study in Gut shows that gastric cancer is shaped by complex interactions between environmental exposure, microbes, host, and tumor biology. The findings reveal distinct cancer routes and targets linked to prognosis and ...
13 hours ago
0
0
Prostate cancer screening is as good as breast cancer screening, say researchers
Prostate cancer screening compares favorably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research. The findings are presented at the European ...
Mar 14, 2026
0
0
How vitamin B2 could pave the way to new cancer therapies
The human body cannot produce vitamin B2—also known as riboflavin—itself; it must absorb the important substance through diet. The vitamin can be found in dairy products, eggs, meat and green vegetables. The metabolism ...
Mar 13, 2026
0
1
Multi-cytokine scaffold helps CAR-T cells fight cancer and HIV for longer
A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into patients to fight cancer ...
Mar 13, 2026
0
0
Enzyme-blocking cream may prevent or slow growth of some common skin cancers, preclinical study reveals
A topical cream activated the skin's immune defenses and suppressed tumor growth in two preclinical models of cutaneous squamous cell carcinoma (cSCC), according to a study published in the Journal of Clinical Investigation.
Mar 13, 2026
0
1
A new triple negative breast cancer target: Why HORMAD1 could guide treatment choices
A gene that is typically active only in reproductive cells may hold the key to new treatments for triple negative breast cancer, according to new research published in the journal Nature Communications. Scientists from the ...
Mar 13, 2026
0
0
Sonodynamic therapy is safe and well-tolerated in high-grade gliomas, first-in-human trial suggests
High-grade gliomas, especially glioblastoma (GBM) and others, remain among the most aggressive brain cancers, with few effective treatment options after the tumor recurs. Even with maximal surgical resection, radiotherapy, ...
Mar 13, 2026
0
1
Dual targeting approach improves immunotherapy response in glioblastoma
Researchers from The University of Texas MD Anderson Cancer Center have found that simultaneously blocking two key "don't eat me signals" found in cancer cells heightens the immune response and sensitizes tumors to immunotherapy ...
Mar 13, 2026
0
1
FDA-approved cancer drug fedratinib reshapes how cell organelles communicate, providing new therapeutic avenues
Cells behave like cities and organelles carry out infrastructural roles: mitochondria are powerhouses, the endoplasmic reticulum serves as a transport hub and lysosomes help with waste disposal. Communication between different ...
Mar 13, 2026
0
0
GLP-1 receptor agonists linked to lower mortality for patients with brain metastases, T2DM
For patients with cancer and brain metastases (BM) and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with significantly lower all-cause mortality, according to a research letter ...
Mar 13, 2026
0
0
Study finds CDK4/6 plus EGFR blockade kills pancreatic cancer cells without KRAS drugs
Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 inhibition offers an indirect ...
Mar 13, 2026
0
0
Bilingual forms improve cancer treatment understanding among people with limited English
People with limited English are significantly more likely to understand the true aim of cancer treatment when given a bilingual consent form, with understanding rising from 35% to 60%, a new study finds. The study, published ...
Mar 13, 2026
0
0
Prenatal stem cell treatment targets rare genetic disease before birth
Stanford Medicine pediatric hematologist Agnieszka Czechowicz, MD, Ph.D., has devoted her research career to improving treatments for rare blood disorders. She's an expert in Fanconi anemia, a genetic disease that interferes ...
Mar 13, 2026
0
0
How 3D and mixed reality can transform bone cancer surgery
When a patient is diagnosed with osteosarcoma, an aggressive form of bone cancer, the mission is to remove the tumor entirely. Leaving behind even a microscopic cluster of malignant cells can be the difference between remission ...
Mar 13, 2026
0
0
Uncovering a key signaling pathway linking liver cancer and fibrosis
New molecular insights into the link between hepatocellular carcinoma and intratumoral fibrosis could lead to better treatment strategies, report researchers from Institute of Science Tokyo. Through a comprehensive analysis ...
Mar 13, 2026
0
0
New strategy intercepts pancreatic cancer by eliminating microscopic lesions before they become cancer
A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors. Using an experimental therapy to target microscopic precancerous lesions in the ...
Mar 12, 2026
0
5
Scientists find a new therapeutic target present on up to half of all tumors
For five decades, scientists have known about a notorious cancer-causing enzyme called SRC. But they always assumed it only appeared on the inside of cells, where it sent signals that fueled tumor growth and stayed hidden ...
Mar 12, 2026
0
0
First-of-its-kind analysis reveals the structural variant landscape driving pediatric cancer development
The first and largest dataset of genomic structure variations specific to childhood cancers was published today by scientists from St. Jude Children's Research Hospital and the National Cancer Institute. The researchers assembled ...
Mar 12, 2026
0
0
Tuning T cells' cancer-killing power via an engineered hydrogel platform
Lymph nodes, considered the command centers of our immune system, often get swollen and stiff when fighting infection. Now, a UC Berkeley-led team of researchers has discovered that this mechanical change may help instruct ...
Mar 12, 2026
0
0
